Liat Hayardeny

Person

Tel-Aviv, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Genetic markers predictive of response to glatiramer acetate
- Patent number 9,702,007
- Issue date Jul 11, 2017
- TEVA PHARMACEUTICALS INDUSTRIES, LTD.
- Amir Tchelet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of BDNF-related disorders using laquinimod
- Patent number 9,585,878
- Issue date Mar 7, 2017
- Teva Pharmaceutical Industries, Ltd.
- Liat Hayardeny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMOD
- Publication number 20180064702
- Publication date Mar 8, 2018
- Teva Pharmaceutical Industries, Ltd.
- Nora Tarcic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE
- Publication number 20180002753
- Publication date Jan 4, 2018
- Teva Pharmaceutical Industries, Ltd.
- Amir TCHELET
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20170354651
- Publication date Dec 14, 2017
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF BDNF-RELATED DISORDERS USING LAQUINIMOD
- Publication number 20170239234
- Publication date Aug 24, 2017
- Teva Pharmaceutical Industries, Ltd.
- Liat Hayardeny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20170224674
- Publication date Aug 10, 2017
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOLOGICAL CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED DRUG PR...
- Publication number 20170003277
- Publication date Jan 5, 2017
- Michael Hayden
- G01 - MEASURING TESTING
Information Patent Application
Treatment of BDNF-Related Disorders Using Laquinimod
- Publication number 20160243103
- Publication date Aug 25, 2016
- Teva Pharmaceutical Industries, Ltd.
- Liat Hayardeny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE EXPRESSION BIOMARKERS OF LAQUINIMOD RESPONSIVENESS
- Publication number 20160201132
- Publication date Jul 14, 2016
- Teva Pharmaceutical Industries Ltd.
- Liat Hayardeny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20160074380
- Publication date Mar 17, 2016
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE
- Publication number 20150110733
- Publication date Apr 23, 2015
- Teva Pharmaceutical Industries, Ltd.
- Amir TCHELET
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE...
- Publication number 20140271532
- Publication date Sep 18, 2014
- Teva Pharmaceutical Industries, Ltd.
- Rivka Kreitman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMOD
- Publication number 20140235670
- Publication date Aug 21, 2014
- Teva Pharmaceutical Industries, Ltd.
- Nora Tarcic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE...
- Publication number 20120027718
- Publication date Feb 2, 2012
- Teva Pharmaceutical Industries, Ltd.
- Rivka Kreitman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of BDNF-related disorders using laquinimod
- Publication number 20110034508
- Publication date Feb 10, 2011
- Liat Hayardeny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Markers associated with the therapeutic efficacy of glatiramer acetate
- Publication number 20100285600
- Publication date Nov 11, 2010
- Teva Pharmaceutical Industries, Ltd.
- Doron Lancet
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combination therapy with glatiramer acetate and rasagiline for the...
- Publication number 20100167983
- Publication date Jul 1, 2010
- Teva Pharmaceutical Industries, Ltd.
- Rivka Kreitman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy with Glatiramer Acetate and Rasagiline for the...
- Publication number 20080261894
- Publication date Oct 23, 2008
- Rivka Kreitman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy With Glatiramer Acetate and Riluzole
- Publication number 20070244056
- Publication date Oct 18, 2007
- Liat Hayardeny
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
Combination therapy with glatiramer acetate and alphacalcidol for t...
- Publication number 20070037740
- Publication date Feb 15, 2007
- Irit Pinchasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Markers associated with the therapeutic efficacy of glatiramer acetate
- Publication number 20060240463
- Publication date Oct 26, 2006
- Rappaport Family Institute for Research in the Medical Sciences
- Doron Lancet
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Propargyl-trifluoromethoxy-amino-benzothiazole derivatives
- Publication number 20040176430
- Publication date Sep 9, 2004
- Jeffrey Sterling
- C07 - ORGANIC CHEMISTRY

Liat Hayardeny

Person

Patents Grantslast 30 patents

Genetic markers predictive of response to glatiramer acetate

Treatment of BDNF-related disorders using laquinimod

Patents Applicationslast 30 patents

TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

TREATMENT OF BDNF-RELATED DISORDERS USING LAQUINIMOD

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

BIOLOGICAL CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED DRUG PR...

Treatment of BDNF-Related Disorders Using Laquinimod

GENE EXPRESSION BIOMARKERS OF LAQUINIMOD RESPONSIVENESS

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE

COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE...

TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE...

Treatment of BDNF-related disorders using laquinimod

Markers associated with the therapeutic efficacy of glatiramer acetate

Combination therapy with glatiramer acetate and rasagiline for the...

Combination Therapy with Glatiramer Acetate and Rasagiline for the...

Combination Therapy With Glatiramer Acetate and Riluzole

Combination therapy with glatiramer acetate and alphacalcidol for t...

Markers associated with the therapeutic efficacy of glatiramer acetate

Propargyl-trifluoromethoxy-amino-benzothiazole derivatives